Regenxbio reported improved muscle function in boys with Duchenne muscular dystrophy using their gene therapy RGX-202. The ...
Company has Babu A Kallivayalil & Co as its auditors. As on 30-09-2024, the company has a total of 64.71 Crore shares outstanding.FACT Share Price Today is Rs. 818.70 as on 14 Nov, 2024, 03:59 PM IST.